Kimberly Manhard
Corporate Officer/Principal at ACADIA PHARMACEUTICALS INC.
Profile
Ms. Kimberly J.
Manhard is a Senior VP-Global Strategic Planning & Execution at ACADIA Pharmaceuticals, Inc. and an Independent Director at Inhibrx Biosciences, Inc. She is on the Board of Directors at Shoreline Biosciences, Inc., Toragen, Inc., Inhibrx Biosciences, Inc. and The Fleet Science Center.
Ms. Manhard was previously employed as an Independent Director by Inhibrx, Inc., an Executive VP-Drug Development by Heron Therapeutics, Inc., a Director & Corporate Compliance Officer by Ardea Biosciences, Inc., a Vice President-Regulatory Affairs by Exelixis, Inc., a Head-Regulatory Affairs by Agouron Global Commercial Operations, a Head-Regulatory Affairs by Bristol Myers Squibb Co., a Principal by Eli Lilly & Co., and a Principal by G.H.
Besselaar Associates.
She received her undergraduate degree from the University of Florida.
Kimberly Manhard active positions
| Companies | Position | Start |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 2024-01-29 |
| Fleet Science Center | Director/Board Member | - |
Shoreline Biosciences, Inc.
 Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Director/Board Member | 2021-05-18 |
Toragen, Inc.
 Toragen, Inc. BiotechnologyHealth Technology Toragen, Inc. is a clinical-stage biotechnology company that is focused on developing treatments for HPV-induced cancers, starting with head and neck cancer. Toragen is based in San Diego, CA. The company is targeting the root cause of virally induced cancers. The company was founded by Andrew Sharabi and the CEO is Sandra I. Coufal. | Director/Board Member | 2020-04-30 |
Former positions of Kimberly Manhard
| Companies | Position | End |
|---|---|---|
| INHIBRX, INC. | Director/Board Member | 2024-05-29 |
| HERON THERAPEUTICS, INC. | Director/Board Member | 2023-02-20 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Chief Operating Officer | 2009-06-22 |
| EXELIXIS, INC. | General Counsel | 2002-12-31 |
| G.H. Besselaar Associates | Corporate Officer/Principal | - |
Training of Kimberly Manhard
| University of Florida | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| EXELIXIS, INC. | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| INHIBRX, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
| Agouron Global Commercial Operations | |
| G.H. Besselaar Associates | |
Shoreline Biosciences, Inc.
Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Health Technology |
| Fleet Science Center | |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Toragen, Inc. is a clinical-stage biotechnology company that is focused on developing treatments for HPV-induced cancers, starting with head and neck cancer. Toragen is based in San Diego, CA. The company is targeting the root cause of virally induced cancers. The company was founded by Andrew Sharabi and the CEO is Sandra I. Coufal. | Health Technology |
- Stock Market
- Insiders
- Kimberly Manhard
